According to Medtech Ventures analysts, the aortic intervention market, which currently stands
at $2 billion, is poised for heightened acquisition activity in 2014.
Medtronic, Cook, Gore, Endologix and Terumo, the top five leading aortic endograft companies,
are not present in all anatomical segments of the market or in all geographical locations.
This represents an intriguing opportunity for consolidation through acquisitions during 2014 and
interesting prospects for the many innovative start-ups that are starving for cash in this difficult
With 71% share, abdominal aortic stent grafts account for the majority of the market. They
experienced a resurgence during the previous three years due to the rollout of new lower profile
devices designed to treat a wider universe of patients with tortuous, angulated aortas that were
previously not eligible for EVAR.
New generations of devices that further expand the universe of patients eligible for
endovascular repair are expected to rollout in major markets with thought leaders predicting
that before the end of the decade close to 90% of aortic aneurysm patients will be treated
The Aortic Intervention Market Report attempts to answer some important questions regarding
the fast evolving aortic intervention landscape. The report examines Leading companies
technologies, product offerings, market shares and strategic positions. It uncovers areas with
maturing trends as well as areas with high growth potential and provides an updated forecast to
Aortic Intervention Market Report is targeted at senior executives in the medical device industry
who wish to get up-to-date with this two billion dollar fast growing market.
With Aortic Intervention Market Report you’ll be better able to:
Examine new strategic landscape and understand evolving market dynamics.
Assess market size and growth rates of leading device segments.
Re-assess market potential and have access to updated forecast.
Understand current market situation, competitors’ positions and market shares.